John David Black, MD
Orthopaedic Surgery · Richland, WANPI 1619105004
Payments from drug & device makers
Across 495 payments — averaging $773.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$375K
- Stryker$3K
- Summit Surgical Corp.$2K
- Johnson & Johnson$1K
- Skeletal Dynamics Inc$778
- Arthrex$757
- plus $891 from 13 others
What the payments were for
- Royalty or licence$22,5417%
- Consulting fees$293,12585%
- Travel & lodging$17,3365%
- Food & beverage$11,1863%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 359 | $374,976 |
| Stryker | 68 | $2,794 |
| Summit Surgical Corp. | 8 | $1,543 |
| Johnson & Johnson | 29 | $1,334 |
| Skeletal Dynamics Inc | 5 | $778 |
| Arthrex | 11 | $757 |
| Globus Medical | 3 | $276 |
| Sanara Medtech Inc. | 1 | $122 |
| Carbofix Orthopedics Inc | 1 | $112 |
| Orthalign Inc | 1 | $103 |
| Kinamed, Inc. | 1 | $81 |
| Innovation Technologies Inc | 1 | $34 |
| Mimedx Group, Inc. | 1 | $28 |
| Nevro Corp. | 1 | $26 |
| Solventum Corporation | 1 | $25 |
| Kerecis Limited | 1 | $24 |
| Abbott | 1 | $22 |
| Polynovo North America LLC | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$234,594
- IFUSE IMPLANT SYSTEM$93,899
- Geminus$635
- Align$635
- IJS$635
- Implate$635
- NA$275
- VARIAX$150
- T2$148
- GAMMA$138
- AXSOS$135
- Distal Femur Plate System$130
- TFN-Advance$125
- CellerateRx$122
- ORTHALIGN PLUS$103
How this compares
$383,073 in reported general payments places this provider in the 95th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Richland
- William BarrettRenton$8.2M
- James PritchettSeattle$6.4M
- Jeffrey RohSeattle$4.7M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.8M
- Burt YaszaySeattle$1.5M
- Sean ToomeySeattle$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.